GYRE icon

Gyre Therapeutics
GYRE

Overview Fund Trends Analyst Outlook Journalist POV

38 hedge funds and large institutions have $707K invested in Gyre Therapeutics in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 26 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

92% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 26

Holders
38
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$18K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$52K
2
+$16K
3
+$12.1K
4
E
Ergoteles
New York
+$10.4K
5
Parallax Volatility Advisers
Parallax Volatility Advisers
California
+$9.15K

Top Sellers

1
-$705K
2
-$310K
3
-$148K
4
Citadel Advisors
Citadel Advisors
Florida
-$126K
5
VF
Virtu Financial
New York
-$69K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$6.65K
27
$4.43K
28
$4.14K
29
$3.28K
30
$2K
31
$1K
32
$207
33
$57
34
$45
35
$38
36
–
37
–
38
–
39
–
1
2